Step Pharma
Saint-Genis-Pouilly, FR · Founded 2014 · 16 employees on LinkedIn · 6 known investors
Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
Founders & leadership
Step Pharma was founded in 2014 by Alain Fischer.
AF
Alain FischerFounding Scientist
Investors · 6
Funding
SEC filings, press & company announcements- Undisclosed amountSeries COct 2025Source ↗
- Undisclosed amountseries BMar 2021 · 2 sources
Hadean Ventures (lead), Sunstone Life Science Ventures (lead), Bpifrance, Kurma Partners, Pontifax
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Step Pharma do?
- Step Pharma develops oral cancer drugs that inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1), with its lead therapeutic dencatistat in clinical development for lymphoma, solid tumors, and essential thrombocythaemia.
- Who founded Step Pharma?
- Step Pharma was founded by Alain Fischer in 2014.
- Who are Step Pharma's investors?
- Step Pharma's investors include Hadean Ventures, Kurma Partners, Bpifrance, Pontifax Venture Capital, Sunstone Capital, V-Bio Ventures.
- Where is Step Pharma headquartered?
- Step Pharma is headquartered in Saint-Genis-Pouilly, FR.